NDT Advance Access published online on August 18, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl499
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Renal Division, S. Paolo Hospital, University of Milan, Milan, Italy
* To whom correspondence should be addressed.
Letter
Decreased serum fetuin-A levels after a single haemodialysis session
Mario Cozzolino 1 *, Andrea Galassi 1, Maria Luisa Biondi 1, Alessandra Butti 1, Micol Russo 2, Carlo Longhini 2, Maurizio Gallieni 1, and Diego Brancaccio 1
2 Chair of Internal Medicine, University of Ferrara, Ferrara, Italy
Mario Cozzolino, E-mail: mariocozzolino{at}hotmail.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. C. Shroff, V. Shah, M. P. Hiorns, M. Schoppet, L. C. Hofbauer, G. Hawa, L. J. Schurgers, A. Singhal, I. Merryweather, P. Brogan, et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3263 - 3271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marino and N. Giotta Cinacalcet, fetuin-A and interleukin-6 Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1460 - 1461. [Full Text] [PDF] |
||||
